The UFHCC recognizes that a common barrier to successful trial completion is inadequate resource allocation. As a steward of limited resources, the UFHCC Feasibility Group (FG) is responsible for reviewing or providing feedback on the non-scientific aspects of a study being considered. The goal is to assist PIs and DSGs in ensuring adequate institutional, financial, personnel and patient resources are available. The UFHCC FG provides this information as a required component of the UFHCC CRO-managed protocol development and as a consultant to other UFHCC investigators. The FG issues a recommendation of feasible or non-feasible for each study reviewed to supplement DSG decision making.
FG meets the first and third Wednesday of the month and submissions for review are due the week prior to the meeting date by 12:00 pm. Protocols and budget drafts should be submitted to Protocol_Activation@cancer.ufl.edu.
Feasibility Group Members
- Associate Director for Clinical Research
Thomas George, M.D., FACP
- Associate Director for Medical Affairs
Merry-Jennifer Markham, M.D.
- Associate Director for Administration
Robert Houlihan, DHA, MBA, FACHE, CCRP, CRA
- Administrative Director
Alison Ivey, R.N., MS, OCN, CCRP
- Assistant Director, Study Coordination & Data Management
Leslie Pettiford, R.N., MS, OCN, CCRC
- Assistant Director, Project Management & Regulatory Affairs
Alisha Daniels, M.D., MHA, CCRC
- Assistant Director, Clinical Research Administration & Compliance
Ashley Anderson, MBA, ACRP-CP
For information related to the Feasibility Group, please contact Alisha Daniels, Assistant Director of Project Management & Regulatory Affairs, at email@example.com or 352.294.8568.